+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Soluble Guanylate Cyclase Stimulators Market by Product Type, Indication, Distribution Channel, End User - Global Forecast to 2030- Product Image
Soluble Guanylate Cyclase Stimulators Market by Product Type, Indication, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Soluble Guanylate Cyclase Stimulators Market by Product Type, Indication, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081229
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers navigating cardiovascular and pulmonary therapeutics are observing rapid change in the soluble guanylate cyclase stimulators market. Innovations, evolving regulations, and complex economic dynamics demand strategic responses to sustain competitive advantage across product portfolios and geographic regions.

Market Snapshot: Soluble Guanylate Cyclase Stimulators Market

The global soluble guanylate cyclase stimulators market is reshaping how nitric oxide signaling is leveraged to address critical vascular disorders. As market size expands and a robust CAGR is projected, the therapeutic class is recognized for its potential in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. Scientific advances, regulatory support, and clinical validation continue to influence both branded and generic adoption, setting up an environment where manufacturers and institutional buyers must anticipate rapid shifts in value perception and patient access.

Scope & Segmentation

This report provides comprehensive segmentation and regional mapping, reflecting actionable developments in pharmacology, market entry, and distribution strategy. Categories tracked include:

  • Product Types: Branded stimulators with proprietary molecular enhancements and generic options optimized for cost efficiency.
  • Indications: Chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension, each driving tailored product development and clinical positioning.
  • Distribution Channels: Hospital pharmacies as primary sites for therapy initiation, online pharmacies supporting outpatients, and retail—independent and chain—crucial for broad accessibility.
  • End Users: Home care settings benefiting from remote monitoring integration, hospitals focusing on acute management, and specialty clinics driving long-term oversight and trial participation.
  • Regional Coverage:
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Key Companies: Bayer AG, Merck & Co., Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi S.A., Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Grünenthal GmbH, NOXXON Pharma N.V.

Key Takeaways for Decision-Makers

  • Soluble guanylate cyclase stimulators' direct activation of nitric oxide signaling components underpins targeted efficacy in major vascular disorders.
  • Strategic alliances between large pharma and biotechs are expediting both innovation and late-stage pipeline development, enabling differentiation in product features and care delivery.
  • Adaptive clinical trial design and broadening regulatory receptivity enable faster translation from laboratory milestones to regulatory approval, especially for unmet clinical needs.
  • Digital health integration, including remote monitoring and real-world data, is actively shaping payer engagement, bolstering evidence for pharmacoeconomic value, and streamlining post-launch patient management.
  • Distinct segmentation across product type, indication, and distribution unlocks tailored commercialization opportunities, while regional differences in reimbursement and healthcare infrastructure impact uptake strategies.

Tariff Impact on Market Dynamics

The upcoming United States tariffs in 2025 are influencing supply chain and procurement strategies for soluble guanylate cyclase stimulators. Increased input costs from new import duties have prompted manufacturers to explore near-shoring and alternative supply sources to maintain profit margins. Hospital formularies and distributors are renegotiating contracts, and while operational efficiencies have helped absorb some price increases, reimbursement pressure persists. Collaboration across manufacturing and distribution will be pivotal to maintain patient access and contain cost escalation effects.

Methodology & Data Sources

This report synthesizes extensive secondary research from industry reports, peer-reviewed literature, regulatory filings, and patent documentation. In-depth interviews with industry executives, clinical specialists, and opinion leaders supplied qualitative context. Modeling, data triangulation, and cross-disciplinary review underpin data reliability and insight rigor.

Why This Report Matters

  • Delivers a strategic framework for prioritizing investment, partnership, and commercialization efforts in the soluble guanylate cyclase stimulators market.
  • Enables organizations to anticipate and mitigate risks associated with tariff changes, supply chain complexity, and regulatory evolution.
  • Provides detailed segmentation and regional insights to inform differentiated market access strategies and competitive positioning decisions.

Conclusion

Senior leaders will find actionable guidance in this report to drive product portfolio performance and operational resilience. By leveraging data-driven insights, organizations are positioned to capture emerging growth and deliver stakeholder value in this evolving therapeutic area.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Soluble Guanylate Cyclase Stimulators Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Soluble Guanylate Cyclase Stimulators Market, by Indication
9.1. Introduction
9.2. Chronic Thromboembolic Pulmonary Hypertension
9.3. Pulmonary Arterial Hypertension
10. Soluble Guanylate Cyclase Stimulators Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Soluble Guanylate Cyclase Stimulators Market, by End User
11.1. Introduction
11.2. Home Care Settings
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Soluble Guanylate Cyclase Stimulators Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Soluble Guanylate Cyclase Stimulators Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Soluble Guanylate Cyclase Stimulators Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Merck & Co., Inc.
15.3.3. Johnson & Johnson
15.3.4. Novartis AG
15.3.5. Pfizer Inc.
15.3.6. Sanofi S.A.
15.3.7. Ironwood Pharmaceuticals, Inc.
15.3.8. Astellas Pharma Inc.
15.3.9. Grünenthal GmbH
15.3.10. NOXXON Pharma N.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET MULTI-CURRENCY
FIGURE 2. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET MULTI-LANGUAGE
FIGURE 3. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 39. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 44. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 70. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 75. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 85. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 90. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 110. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 120. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 125. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 140. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 145. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. ISRAEL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. ISRAEL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. NORWAY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. NORWAY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. NORWAY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. NORWAY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 155. NORWAY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. POLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. POLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. POLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. POLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 160. POLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SWITZERLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SWITZERLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. CHINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. CHINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. CHINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. CHINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 176. CHINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. INDIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. INDIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. INDIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. INDIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. INDIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. JAPAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. JAPAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. JAPAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. JAPAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 186. JAPAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. THAILAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. THAILAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. THAILAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. THAILAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 206. THAILAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. VIETNAM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 233. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Soluble Guanylate Cyclase Stimulators market report include:
  • Bayer AG
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Ironwood Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • Grünenthal GmbH
  • NOXXON Pharma N.V.

Related Topics

Related Reports

Soluble Guanylate Cyclase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Soluble Guanylate Cyclase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 79 Pages
  • Global
From
Guanylate Cyclase (Guanyl Cyclase Or Guanylyl Cyclase Or GC) Activators - Pipeline Insight, 2025 - Product Image

Guanylate Cyclase (Guanyl Cyclase Or Guanylyl Cyclase Or GC) Activators - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2025 - Product Image

Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Terpene Synthases. Methods in Enzymology Volume 699 - Product Image

Terpene Synthases. Methods in Enzymology Volume 699

  • Book
Pseudokinases. Methods in Enzymology Volume 667 - Product Image

Pseudokinases. Methods in Enzymology Volume 667

  • Book
Copyright © 2002-2025 Research and Markets. All Rights Reserved.